We show that the treatment of IMiD-sensitive MM cells with lenalidomide significantly increased CRBN, subsequently decreasing both AGO2 protein and its target miRNAs and inducing apoptosis. The gene discussed is CRBN; the disease is Miyoshi myopathy.